收藏 分享
收录年代
序号 标题 作者 起始页 操作
1 Letter to the editor: Using angiotensin‐converting enzyme inhibitors to prevent liver‐related events in NAFLD—Revisiting the renin–angiotensin–aldosterone system pathways Manas Kumar Panigrahi, Prajna Anirvan
2 Reply Ji Zhang, Tingting Zhao, Lai Wei...
3 Reply Amit G. Singal, Neehar D. Parikh
4 Reply Xinrong Zhang, Grace Lai‐Hung Wong, Terry Cheuk‐Fung Yip...
5 Letter to the editor: GALAD score: Superior surveillance strategy or not? Anurag Sachan, Saraswati Kushwah
6 Letter to the editor: The burgeoning field of progressive familial intrahepatic cholestasis Claudia Mandato, Pietro Vajro
7 Letter to the editor: Regression of liver fibrosis after bariatric operations: A glass two‐third full rather than half empty Fran?ois Pattou, Guillaume Lasailly, Violeta Raverdy...
8 Letter to the editor: Effect of diabetes medications and glycemic control on risk of HCC in patients with NAFLD Yibing Zhou, Weike Chu, Xue Wu...
9 Letter to the editor: Nanoparticle therapeutic vaccine for hepatitis B: An unfulfilled dream Ajay Kumar Patwa, Sumit Rungta, Vivek Kumar 29
10 Letter to the editor Yonghao Chen, Chunhui Wang 36